data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
VistaGen Therapeutics
(NASDAQ:VTGN)
$0.8881
0.016[1.83%]
Last update: 12:36PM
Day High/Low0.83 - 0.9
52 Week High/Low0.86 - 3.55
Open / Close0.88 / -
Float / Outstanding206.4M / 206.6M
Vol / Avg.320.6K / 1.4M
Mkt Cap183.5M
P/E-
50d Avg. Price1.11
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float206.4M

VistaGen Therapeutics (NASDAQ:VTGN), Quotes and News Summary

VistaGen Therapeutics (NASDAQ: VTGN)

Day High/Low0.83 - 0.9
52 Week High/Low0.86 - 3.55
Open / Close0.88 / -
Float / Outstanding206.4M / 206.6M
Vol / Avg.320.6K / 1.4M
Mkt Cap183.5M
P/E-
50d Avg. Price1.11
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float206.4M
Benzinga - Jun 23, 2022, 4:52PM
Benzinga - Jun 23, 2022, 4:26PM
Benzinga - Jun 22, 2022, 8:34AM
Benzinga - May 5, 2022, 8:42AM
Benzinga - Apr 12, 2022, 7:08AM
Benzinga - Apr 11, 2022, 12:05PM
Benzinga - Feb 11, 2022, 10:25AM
Benzinga - Feb 10, 2022, 4:52PM
Benzinga - Nov 10, 2021, 5:45PM
Benzinga - Sponsored
Benzinga - Oct 14, 2021, 8:07AM
Benzinga - Sponsored
Benzinga - Oct 5, 2021, 8:03AM
Benzinga - Sep 13, 2021, 6:09AM
Benzinga - Sep 1, 2021, 10:11AM
Benzinga - Aug 18, 2021, 9:40AM
Sector: Health Care.Industry: Biotechnology
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.
Read More

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q4 2022Est.ActualSurprise
EPS-0.060-0.090 -0.0300
REV350.000K38.900K-311.100K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

VistaGen Therapeutics Questions & Answers

Q
How do I buy VistaGen Therapeutics (VTGN) stock?
A

You can purchase shares of VistaGen Therapeutics (NASDAQ: VTGN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are VistaGen Therapeutics's (VTGN) competitors?
Q
What is the target price for VistaGen Therapeutics (VTGN) stock?
A

The latest price target for VistaGen Therapeutics (NASDAQ: VTGN) was reported by Baird on Thursday, May 20, 2021. The analyst firm set a price target for 9.00 expecting VTGN to rise to within 12 months (a possible 913.40% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for VistaGen Therapeutics (VTGN)?
A

The stock price for VistaGen Therapeutics (NASDAQ: VTGN) is $0.8881 last updated Today at July 5, 2022, 4:36 PM UTC.

Q
Does VistaGen Therapeutics (VTGN) pay a dividend?
A

There are no upcoming dividends for VistaGen Therapeutics.

Q
When is VistaGen Therapeutics (NASDAQ:VTGN) reporting earnings?
A

VistaGen Therapeutics’s Q1 earnings are confirmed for Thursday, August 11, 2022.

Q
Is VistaGen Therapeutics (VTGN) going to split?
A

There is no upcoming split for VistaGen Therapeutics.

Q
What sector and industry does VistaGen Therapeutics (VTGN) operate in?
A

VistaGen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.